Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Health Canada Introduces Trial Rules in Wake of Tuberculosis Scare

October 24, 2006

Health Canada introduced new clinical drug trial rules intended to screen out TB-infected participants after a study last year in Montreal included a man with the disease, thus exposing dozens. The binding rules require Phase I trials to screen all potential participants for TB symptoms and to ask if they use IV drugs or have HIV. Trial candidates would be asked if they ever had TB, and whether they ever experienced unexplained chest pains, weight loss, fever, loss of appetite, night sweats or had coughed up blood. If a candidate answers yes to any of the questions and has not been tested or examined to exclude the possibility of being TB-infected, his or her participation in the trial is prohibited by federal law. The rules are a response to reports of a clinical drug trial held last year by SFBC Anapharm, in which a subject with active, visible signs of TB was allegedly housed on-site with trial participants and staff members. Earlier this year, 20 people in that trial tested positive for exposure to the disease.

Back to other news for October 24, 2006

Adapted from:
Canadian Press
10.15.2006; Dene Moore


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement